• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2000 年至 2009 年上海幽门螺杆菌对抗生素的耐药性。

Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai.

机构信息

Department of Gastroenterology, Shanghai Renji Hospital, Shanghai Institute of Digestive Disease, Shanghai Jiaotong University School of Medicine, Shanghai 200001, China.

出版信息

World J Gastroenterol. 2010 Oct 28;16(40):5118-21. doi: 10.3748/wjg.v16.i40.5118.

DOI:10.3748/wjg.v16.i40.5118
PMID:20976850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2965290/
Abstract

AIM

To investigate the resistance of Helicobacter pylori (H. pylori) to 6 commonly used antibiotics from 2000 to 2009 in Shanghai.

METHODS

A total of 293 H. pylori strains were collected from 2000 to 2009 in Shanghai and tested for their susceptibility to metronidazole, clarithromycin, amoxicillin, furazolidone, levofloxacin and tetracycline using agar dilution.

RESULTS

The resistant rates of H. pylori to clarithromycin (8.6%, 9.0% and 20.7%) and levofloxacin (10.3%, 24.0% and 32.5%) increased from 2000 to 2009 in Shanghai. The resistant rate of H. pylori to metronidazole remained stable (40%-50%). Only one strain of H. pylori isolated in 2005 was resistant to tetracycline. All strains were sensitive to amoxicillin and furazolidone. The resistant rate of H. pylori to antibiotics was not related with the sex, age and clinical outcome of patients.

CONCLUSION

Resistance of H. pylori to antibiotics plays an important role in making treatment strategies against H. pylori-associated diseases.

摘要

目的

研究 2000 年至 2009 年上海地区幽门螺杆菌(H. pylori)对 6 种常用抗生素的耐药性。

方法

2000 年至 2009 年期间,从上海共收集 293 株 H. pylori 菌株,采用琼脂稀释法检测其对甲硝唑、克拉霉素、阿莫西林、呋喃唑酮、左氧氟沙星和四环素的敏感性。

结果

2000 年至 2009 年,上海地区 H. pylori 对克拉霉素(8.6%、9.0%和 20.7%)和左氧氟沙星(10.3%、24.0%和 32.5%)的耐药率呈上升趋势。H. pylori 对甲硝唑的耐药率保持稳定(40%-50%)。2005 年分离的一株 H. pylori 对四环素耐药。所有菌株均对阿莫西林和呋喃唑酮敏感。H. pylori 对抗生素的耐药率与患者的性别、年龄和临床结局无关。

结论

H. pylori 对抗生素的耐药性在制定针对 H. pylori 相关疾病的治疗策略中起着重要作用。

相似文献

1
Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai.2000 年至 2009 年上海幽门螺杆菌对抗生素的耐药性。
World J Gastroenterol. 2010 Oct 28;16(40):5118-21. doi: 10.3748/wjg.v16.i40.5118.
2
Antibiotic resistance of Helicobacter pylori in Chinese children: A multicenter study from 2016 to 2023.中国儿童幽门螺杆菌的抗生素耐药性:一项 2016 年至 2023 年的多中心研究。
Helicobacter. 2024 Jan-Feb;29(1):e13038. doi: 10.1111/hel.13038. Epub 2023 Nov 20.
3
Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.尼泊尔幽门螺杆菌左氧氟沙星耐药性的出现及新的基因突变
BMC Microbiol. 2016 Nov 4;16(1):256. doi: 10.1186/s12866-016-0873-6.
4
Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in Ningxia.宁夏地区幽门螺杆菌表型耐药特征及其与基因型耐药的相关性:一项回顾性研究。
Helicobacter. 2023 Jun;28(3):e12960. doi: 10.1111/hel.12960. Epub 2023 Apr 11.
5
Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for Infection in the Dominican Republic.基于克拉霉素的三联疗法仍可用作多米尼加共和国感染的初始治疗方法。
Am J Trop Med Hyg. 2017 May;96(5):1050-1059. doi: 10.4269/ajtmh.16-0729. Epub 2017 Feb 13.
6
Antibiotic resistance of Helicobacter pylori isolated from children in Chongqing, China.中国重庆儿童分离的幽门螺杆菌的抗生素耐药性。
Eur J Pediatr. 2022 Jul;181(7):2715-2722. doi: 10.1007/s00431-022-04456-1. Epub 2022 Apr 25.
7
Antibiotic resistance of isolated from patients in Nanjing, China: A cross-section study from 2018 to 2021.从中国南京患者中分离的 的抗生素耐药性:2018 年至 2021 年的横断面研究。
Front Cell Infect Microbiol. 2022 Sep 8;12:970630. doi: 10.3389/fcimb.2022.970630. eCollection 2022.
8
Dynamics of antimicrobial resistance of Helicobacter pylori isolates in the Smolensk region of Russian Federation.俄罗斯联邦斯摩棱斯克地区幽门螺杆菌分离株的抗菌药物耐药性动态。
Helicobacter. 2018 Dec;23(6):e12545. doi: 10.1111/hel.12545. Epub 2018 Oct 16.
9
High Helicobacter pylori resistance to metronidazole and clarithromycin in Brazilian children and adolescents.巴西儿童和青少年的幽门螺杆菌对甲硝唑和克拉霉素的耐药率较高。
J Pediatr Gastroenterol Nutr. 2013 Jun;56(6):645-8. doi: 10.1097/MPG.0b013e31828b3669.
10
Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan.台湾地区基于克拉霉素治疗前后幽门螺杆菌对甲硝唑、克拉霉素和左氧氟沙星的耐药性
J Gastroenterol Hepatol. 2009 Jul;24(7):1230-5. doi: 10.1111/j.1440-1746.2009.05829.x. Epub 2009 May 19.

引用本文的文献

1
Furazolidone susceptibility of Helicobacter pylori isolated from patients with gastroduodenal diseases in Colombia.从哥伦比亚胃十二指肠疾病患者中分离出的幽门螺杆菌对呋喃唑酮的敏感性
Rev Inst Med Trop Sao Paulo. 2025 Apr 4;67:e20. doi: 10.1590/S1678-9946202567020. eCollection 2025.
2
Effects of fucoidan and synbiotics supplementation during bismuth quadruple therapy of infection on gut microbial homeostasis: an open-label, randomized clinical trial.岩藻多糖和合生元补充剂在铋四联疗法治疗幽门螺杆菌感染期间对肠道微生物稳态的影响:一项开放标签、随机临床试验。
Front Nutr. 2024 Jul 1;11:1407736. doi: 10.3389/fnut.2024.1407736. eCollection 2024.
3
Study on the value of antibiotic-resistant gene detection in in China.中国抗生素耐药基因检测的价值研究。
Exp Ther Med. 2022 Mar;23(3):228. doi: 10.3892/etm.2022.11153. Epub 2022 Jan 18.
4
Antibiotic Resistance of Helicobacter pylori Isolated from Patients after Partial Gastrectomy: A Retrospective Study.胃大部切除术后患者分离的幽门螺杆菌的抗生素耐药性:一项回顾性研究。
Turk J Gastroenterol. 2021 Dec;32(12):996-1002. doi: 10.5152/tjg.2020.19354.
5
Utilizing Probiotics for the Prevention and Treatment of Gastrointestinal Diseases.利用益生菌预防和治疗胃肠道疾病。
Front Microbiol. 2021 Aug 9;12:689958. doi: 10.3389/fmicb.2021.689958. eCollection 2021.
6
A randomized, multicenter and noninferiority study of amoxicillin plus berberine vs tetracycline plus furazolidone in quadruple therapy for Helicobacter pylori rescue treatment.阿莫西林加小檗碱与四环素加呋喃唑酮四联疗法补救治疗幽门螺杆菌的随机、多中心、非劣效性研究。
J Dig Dis. 2020 May;21(5):256-263. doi: 10.1111/1751-2980.12870. Epub 2020 Jun 9.
7
Outcomes of furazolidone- and amoxicillin-based quadruple therapy for infection and predictors of failed eradication.呋喃唑酮和阿莫西林四联疗法治疗感染的结果及根除失败的预测因素。
World J Gastroenterol. 2018 Oct 28;24(40):4596-4605. doi: 10.3748/wjg.v24.i40.4596.
8
Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.铋剂四联疗法(含阿莫西林或四环素)与奥美拉唑、甲硝唑三联疗法作为一线治疗方案根除十二指肠溃疡患者幽门螺杆菌的疗效和耐受性:一项随机临床试验。
PLoS One. 2018 Jun 11;13(6):e0197096. doi: 10.1371/journal.pone.0197096. eCollection 2018.
9
Efficacy and Safety of Wei Bi Mei, a Chinese Herb Compound, as an Alternative to Bismuth for Eradication of .胃铋镁,一种中药复方,作为铋剂替代物用于根除幽门螺杆菌的疗效和安全性。 (注:原文句末不完整,推测补充了“幽门螺杆菌”使句子完整通顺,以便准确翻译)
Evid Based Complement Alternat Med. 2018 Feb 5;2018:4320219. doi: 10.1155/2018/4320219. eCollection 2018.
10
Resistance of to furazolidone and levofloxacin: A viewpoint.对呋喃唑酮和左氧氟沙星的耐药性:一种观点。
World J Gastroenterol. 2017 Oct 7;23(37):6920-6922. doi: 10.3748/wjg.v23.i37.6920.

本文引用的文献

1
Treatment of Helicobacter pylori.幽门螺杆菌的治疗。
Best Pract Res Clin Gastroenterol. 2007;21(2):315-24. doi: 10.1016/j.bpg.2006.11.001.
2
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.幽门螺杆菌感染管理的当前概念:马斯特里赫特III共识报告。
Gut. 2007 Jun;56(6):772-81. doi: 10.1136/gut.2006.101634. Epub 2006 Dec 14.
3
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial.基于左氧氟沙星的10天疗法治疗幽门螺杆菌耐药感染患者:一项对照试验。
Clin Gastroenterol Hepatol. 2004 Nov;2(11):997-1002. doi: 10.1016/s1542-3565(04)00458-6.
4
High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy.克拉霉素和甲硝唑的高水平双重耐药以及左氧氟沙星对治疗失败患者幽门螺杆菌分离株的体外活性。
Int J Antimicrob Agents. 2004 Nov;24(5):433-8. doi: 10.1016/j.ijantimicag.2004.02.032.
5
New mutation points in 23S rRNA gene associated with Helicobacter pylori resistance to clarithromycin in northeast China.中国东北地区23S rRNA基因中与幽门螺杆菌对克拉霉素耐药相关的新突变位点
World J Gastroenterol. 2004 Apr 1;10(7):1075-7. doi: 10.3748/wjg.v10.i7.1075.
6
Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.治疗前进行抗菌药物敏感性测试在根除幽门螺杆菌方面可节省成本。
Clin Gastroenterol Hepatol. 2003 Jul;1(4):273-8.
7
Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates.幽门螺杆菌临床分离株的抗菌药敏性及毒力因子分析
BMC Gastroenterol. 2003 Aug 11;3:20. doi: 10.1186/1471-230X-3-20.
8
Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori.比较Etest法与美国国家临床实验室标准委员会(NCCLS)认可的琼脂稀释法检测耐甲硝唑和克拉霉素幽门螺杆菌的效果。
Int J Antimicrob Agents. 2001 Jan;17(1):39-44. doi: 10.1016/s0924-8579(00)00320-4.
9
Review article: Helicobacter pylori and gastric cancer--the clinicians'point of view.综述文章:幽门螺杆菌与胃癌——临床医生的观点
Aliment Pharmacol Ther. 2000 Oct;14 Suppl 3:48-54. doi: 10.1046/j.1365-2036.2000.00100.x.
10
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.胃炎和消化性溃疡患者胃内不明弯曲杆菌。
Lancet. 1984 Jun 16;1(8390):1311-5. doi: 10.1016/s0140-6736(84)91816-6.